Clinical Experience with Ropeginterferon Alfa-2b in the Off-Label Use for the Treatment of COVID-19 Patients in Taiwan
- Kuan Yuan Chen
- , Kang Yun Lee
- , Albert Qin
- , Ching Shan Luo
- , Yun Kai Yeh
- , Jing Quan Zheng
- , Ching Mei Chen
- , Chan Yen Tsai
- , Sheena Lin
- , Jason Liao
- , Yi Wen Huang
- , Po Hao Feng
- TMU Research Center of Thoracic Medicine
- Taipei Medical University Shuang Ho Hospital
- Graduate Institute of Clinical Medicine
- International Ph.D. Program in Cell Therapy and Regenerative Medicine
- International Master Program in Medicine
- TMU Research Center of Cell Therapy and Regeneration Medicine
- TMU Research Center of Biomedical Devices
- TMU Research Center of Artificial Intelligence in Medicine and Health
- Master Program in Clinical Genomics and Proteomics
- Division of Pulmonary Medicine
- Taipei Medical University Hospital
- Division of Gastroenterology and Hepatology
- TMU Research Center of Urology and Kidney
- TMU Research Center for Digestive Medicine
- TMU Research Center of Cancer Translational Medicine
- The Ph.D. Program for Translational Medicine
- Department of Internal Medicine
- International Ph.D. Program in Medicine
Research output: Contribution to journal › Article › peer-review
8
Link opens in a new tab
Citations
(Scopus)